“Ola Electric founder-promoter has undertaken a one-time, limited monetisation of a small portion of his personal stake to fully repay a promoter level loan amounting to INR 260 crore. With this, all of the previously pledged 3.93% shares will be released, removing a critical overhang,” the company said in a regulatory filing.
The shares were sold for Rs 34.99 per share, valuing the total transaction at approximately Rs 92 crore.
As per available disclosures, Aggarwal’s stake in the electric two-wheeler manufacturer stood at 30.02% as of September 30, 2025, which translates to a holding of over 132 crore equity shares.
The recent bulk deal represents a portion of that stake.
The development comes at a time when Ola Electric’s share price has been under pressure. On Tuesday, the stock ended 8.5% lower at Rs 34.20 on the NSE. The stock had earlier hit its 52-week low of Rs 33.20 on December 9.
“Post the transaction, the promoter group would continue to hold approximately 34% in Ola Electric, among the highest across new-age listed companies. There is no dilution of promoter control or change in the long-term conviction,” the company clarified.With the latest fall, the stock now trades at a 55% discount to its IPO issue price of Rs 76. The scrip had reached a high of Rs 102.50 in December last year.
Sensex, Nifty today: Catch all the LIVE stock market action here
Ola Electric was listed following a public issue worth Rs 6,146 crore, which was oversubscribed 4.45 times, including strong demand in the retail category. However, the company’s listing was flat on both the BSE and NSE.
Market performance aside, Ola Electric has also faced challenges on the business front. The company slipped to fifth place in terms of sales in October, trailing behind competitors like Bajaj, TVS, Hero, and Ather.
In November, unit sales fell to about 8,400, marking a decline from earlier figures.
Financially, the company has reported consecutive quarterly losses. The consolidated net loss for the September 2025 quarter stood at Rs 418 crore, which was narrower than the Rs 495 crore loss in the same quarter last year. However, revenue dropped sharply by 43% year-on-year, to Rs 756 crore.
Also read: Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times.)